Natasha Leskovsek

Of Counsel

I’ve taken my clinical and consulting experience for pharma and biotech companies on regulatory issues and brought them to Cooley’s clients.

nleskovsek@cooley.com

Natasha Leskovsek advises pharmaceutical, biotechnology, medical device and food/dietary supplement industry clients on US Food and Drug Administration regulatory and clinical development matters. She also conducts regulatory diligence on behalf of entities investing in FDA-regulated companies.

Download full bio 

Experience

  • Flexion Therapeutics Agrees to Sell to Pacira BioSciences 

  • Warby Parker – Direct Listing 

  • ZOLL Medical Agrees to Acquire Itamar Medical for $538 Million 

  • Vividion Therapeutics Agrees to Sell to Bayer for up to $2 Billion 

  • Lyell Immunopharma – $425 Million IPO 

  • View all

Passions

    Providing practical compliance solutions at the intersection of science and regulation

Education

  • Georgetown University Law Center
    JD, 1996

  • University of Maryland, College Park
    MBA, 1991

  • University of Maryland, College Park
    MPM, 1991

  • University of Maryland, Baltimore
    BSN, 1989


Admissions & Credentials

District of Columbia

Maryland

Memberships

  • American Health Lawyers Association

  • Food and Drug Law Institute